17th January 2018 – Nottingham, UK – A team of Sygnature Discovery chemists has made it to the final of the 5th National RSC/SCI Retrosynthesis Competition in London on 16th March 2018.
This prestigious event will showcase the calibre of UK chemists from both industry and academia and provide a platform for them to demonstrate their retrosynthetic and forward synthetic prowess. For many years, the UK has produced high calibre synthetic organic chemists, so the Sygnature team – known as “Mannich Black” – will be fighting it out with the creme de la creme of UK-based chemists.
Sygnature Discovery is the UK’s largest independent provider of integrated drug discovery resource and expertise. Private equity-backed, Sygnature undertakes integrated drug discovery programmes for pharmaceutical and biotech companies located around the world. Since 2011, 11 compounds invented at Sygnature for its clients have entered clinical trials (Phases I and II).
Sygnature Discovery’s chemistry department employs 120 medicinal/synthetic chemists (80% with PhDs), making it one of the largest and most experienced chemistry departments in the UK pharmaceutical sector.